Erythropoietin (EPO) Increases Myelin Gene Expression in CG4 Oligodendrocyte Cells through the Classical EPO Receptor
Abstract Erythropoietin (EPO) has protective effects in neurodegenerative and neuroinflammatory diseases, including in animal models of multiple sclerosis, where EPO decreases disease severity. EPO also promotes neurogenesis and is protective in models of toxic demyelination. In this study, we asked...
Saved in:
Main Authors: | Ilaria Cervellini (Author), Alexander Annenkov (Author), Thomas Brenton (Author), Yuti Chernajovsky (Author), Pietro Ghezzi (Author), Manuela Mengozzi (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2013-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leukemia inhibitory factor inhibits erythropoietin-induced myelin gene expression in oligodendrocytes
by: Georgina Gyetvai, et al.
Published: (2018) -
Correction to: Leukemia inhibitory factor inhibits erythropoietin-induced myelin gene expression in oligodendrocytes
by: Georgina Gyetvai, et al.
Published: (2020) -
Erythropoietin Receptor (EpoR) Agonism Is Used to Treat a Wide Range of Disease
by: Fabian Sanchis-Gomar, et al.
Published: (2013) -
Effect of Topical Erythropoietin (EPO) on palatal wound healing subsequent to Free Gingival Grafting (FGG)
by: Siamak YAGHOBEE, et al.
Published: (2018) -
Therapy of an incomplete spinal cord injury by intrathecal injection of EPO and subcutaneous injection of EPO, vitamin C and G-CSF
by: Bader A, et al.
Published: (2017)